531 POSTER Phase 1 dose-escalation study of intravenous recombinant human interleukin-21 (IL-21) in patients with metastatic melanoma: preliminary results of tolerability and effect on immunologic biomarkers

• 卷第3卷
• 期第2期
• 文件大小157.36KB
• 发表时间2005
• DOI10.1016/s1359-6349(05)80827-4